A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia
Condition: Schizophrenia Interventions: Drug: Brexpiprazole LAI: Dose 1; Drug: Brexpiprazole LAI: Dose 2; Drug: Brexpiprazole LAI: Dose 3; Drug: Brexpiprazole LAI: Dose 4 Sponsor: Otsuka Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials